CH676990A5 - - Google Patents

Download PDF

Info

Publication number
CH676990A5
CH676990A5 CH4680/86A CH468086A CH676990A5 CH 676990 A5 CH676990 A5 CH 676990A5 CH 4680/86 A CH4680/86 A CH 4680/86A CH 468086 A CH468086 A CH 468086A CH 676990 A5 CH676990 A5 CH 676990A5
Authority
CH
Switzerland
Prior art keywords
superoxide dismutase
human
sep
mnsod
plasmid
Prior art date
Application number
CH4680/86A
Other languages
German (de)
English (en)
Inventor
Jacob R Hartmann
Yaffa Beck
Original Assignee
Bio Technology General Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Technology General Corp filed Critical Bio Technology General Corp
Publication of CH676990A5 publication Critical patent/CH676990A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CH4680/86A 1985-11-22 1986-11-21 CH676990A5 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80109085A 1985-11-22 1985-11-22
US90705186A 1986-09-12 1986-09-12

Publications (1)

Publication Number Publication Date
CH676990A5 true CH676990A5 (fr) 1991-03-28

Family

ID=27122291

Family Applications (1)

Application Number Title Priority Date Filing Date
CH4680/86A CH676990A5 (fr) 1985-11-22 1986-11-21

Country Status (21)

Country Link
JP (2) JP2609449B2 (fr)
AT (1) AT400443B (fr)
AU (1) AU607897B2 (fr)
BE (1) BE905796A (fr)
CA (1) CA1341362C (fr)
CH (1) CH676990A5 (fr)
DE (1) DE3639725C2 (fr)
DK (1) DK534686A (fr)
ES (1) ES2003518A6 (fr)
FI (1) FI90353C (fr)
FR (1) FR2590591B1 (fr)
GB (1) GB2183658B (fr)
GR (1) GR862713B (fr)
HK (1) HK75195A (fr)
IE (1) IE59498B1 (fr)
IL (2) IL106449A (fr)
IT (1) IT1205418B (fr)
LU (1) LU86676A1 (fr)
NL (1) NL8602960A (fr)
PT (1) PT83792B (fr)
SE (1) SE8604884L (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0587055A1 (fr) * 1992-09-09 1994-03-16 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Utilisation de manganèse superoxyde dismutase (Mn-SOD) en bas dosage pour la production de médicaments pour le traitement de maladies

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610520B1 (en) 1985-11-22 2003-08-26 Bio-Technology General Corp. Gene encoding human manganese superoxide dismutase and recombinant polypeptide encoded thereby
JPS62215532A (ja) * 1986-03-18 1987-09-22 Ube Ind Ltd 抗炎症剤
JPH0643341B2 (ja) * 1986-03-27 1994-06-08 宇部興産株式会社 臓器機能改善剤
JPH0643340B2 (ja) * 1986-09-03 1994-06-08 宇部興産株式会社 虚血性心疾患治療薬
JPS6377822A (ja) * 1986-09-18 1988-04-08 Ube Ind Ltd 臓器機能改善剤
US6326003B1 (en) 1986-10-14 2001-12-04 Chiron Corporation Manganese superoxide dismutase cloning and expression in microorganisms
US5260204A (en) * 1987-03-14 1993-11-09 Boehringer Ingelheim International Gmbh Human manganese superoxide dismutase (hMn-SOD)
EP0676472A1 (fr) * 1987-03-14 1995-10-11 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Manganèse-superoxyde dismutase humaine (hMn-SOD)
EP0691401A1 (fr) * 1987-03-27 1996-01-10 Bio-Technology General Corporation Analogues de manganèse superoxide dismutase humaine, compositions pharmaceutiques les contenant et leur utilisation
JPH01233228A (ja) * 1988-03-11 1989-09-19 Toyo Jozo Co Ltd 悪性腫瘍細胞転移防止剤
US5772996A (en) * 1990-08-03 1998-06-30 Public Health Laboratory Service Board Pharmaceutical compositions containing superoxide dismutase from Bacillus Stearothermophilus and Bacillus Caldotenax
DE4038563A1 (de) * 1990-12-04 1992-06-11 Gruenenthal Gmbh Verwendung von superoxiddismutasen zur prophylaxe und/oder behandlung von organversagen bei risikopatienten mit polytrauma
DE4239877C1 (de) * 1992-11-27 1994-03-17 Boehringer Ingelheim Int Stabilisierte Superoxid-Dismutase (SOD)-Zusammensetzung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56102787A (en) * 1980-01-18 1981-08-17 Mamoru Sugiura Preparation of human placenta superoxide dismutase
BG49718A3 (en) * 1983-07-15 1992-01-15 Bio Technology General Corp Method for preparing of polypeptid with superoxiddismutasne activitty
EP0138111B1 (fr) * 1983-10-03 1991-11-21 Chiron Corporation Clonage de la dismutase du peroxyde et expression dans des micro-organismes

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0587055A1 (fr) * 1992-09-09 1994-03-16 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Utilisation de manganèse superoxyde dismutase (Mn-SOD) en bas dosage pour la production de médicaments pour le traitement de maladies

Also Published As

Publication number Publication date
JP2967557B2 (ja) 1999-10-25
AU6497586A (en) 1987-05-28
SE8604884D0 (sv) 1986-11-14
HK75195A (en) 1995-05-26
AT400443B (de) 1995-12-27
IE59498B1 (en) 1994-03-09
DK534686D0 (da) 1986-11-07
FR2590591A1 (fr) 1987-05-29
ES2003518A6 (es) 1988-11-01
GB8627294D0 (en) 1986-12-17
GB2183658B (en) 1990-04-25
ATA308986A (de) 1995-05-15
DE3639725C2 (de) 1998-02-19
IE862851L (en) 1987-05-22
JPS62289187A (ja) 1987-12-16
FI864756A0 (fi) 1986-11-21
CA1341362C (fr) 2002-05-28
GB2183658A (en) 1987-06-10
IT8667865A0 (it) 1986-11-21
IL106449A (en) 1997-02-18
FI864756A (fi) 1987-05-23
IL106449A0 (en) 1993-11-15
IL80702A0 (en) 1987-02-27
JP2609449B2 (ja) 1997-05-14
DE3639725A1 (de) 1987-07-23
BE905796A (fr) 1987-03-16
DK534686A (da) 1987-05-23
NL8602960A (nl) 1987-06-16
GR862713B (en) 1987-03-24
FI90353C (fi) 1994-01-25
LU86676A1 (fr) 1987-05-04
FI90353B (fi) 1993-10-15
FR2590591B1 (fr) 1989-12-01
IT1205418B (it) 1989-03-15
PT83792B (pt) 1989-01-17
SE8604884L (sv) 1987-05-23
PT83792A (en) 1986-12-01
AU607897B2 (en) 1991-03-21
JPH08289792A (ja) 1996-11-05

Similar Documents

Publication Publication Date Title
EP0282899B1 (fr) La manganèse-superoxyde-dismutase humaine (hMn-SOD)
EP0099084B1 (fr) Procédé de préparation d'interféron et des vecteurs d'expression pour celui-ci
DE69434414T2 (de) Phosphatase oder ein entsprechendes derivat enthaltene pharmazeutische zusammensetzung
EP0764172B1 (fr) Analogues peptidiques de synthese de la proteine sp-c de surfactant
EP0288809B1 (fr) Protéines bifonctionnelles
DD229427A5 (de) Verfahren zur gewinnung eines polypeptids
AT400443B (de) Menschliche mangan-superoxiddismutase cdna, ihre expression in bakterien und verfahren zur gewinnung enzymatisch aktiver, menschlicher mangan-superoxiddismutase
DE69533443T2 (de) Die herstellung von biologisch aktiven, rekombinanten und neurotrophem protein
DD299318A5 (de) Gereinigter ziliarer neurotrophischer faktor
DE69535704T2 (de) EXPRESSIONSPLASMIDE, DURCH EINEN osmB PROMOTER REGULIERT
DE19535853C2 (de) Varianten des rekombinanten humanen Interferon-gamma, Verfahren zu ihrer Herstellung und ihre Verwendung
DD219505A5 (de) Verfahren zur herstellung von schweine-wachstumshormonaehnlichen polypeptiden
DE60127561T2 (de) Phagen-abhängige superproduktion biologisch aktiver proteine und peptide
JPH08317789A (ja) ヒトマンガンスーパーオキシドジスムターゼ類似体及びそれを含む薬剤組成物
EP0786004B1 (fr) Clonage, expression et caracterisation d'une nouvelle forme de phosphatidylinositol-3-kinase
US6361772B1 (en) Human manganese superoxide dismutase DNA, its expression and method of recovering human manganese superoxide dismutase
US5246847A (en) Polypeptide analogs of human manganese superoxide dismutase and compositions and complexes thereof
EP0244627A2 (fr) Vecteurs d'expression pour la production de polypeptides
US5270195A (en) Plasmids for expression and method of producing a human manganese superoxide dimutase analog
DE69635178T2 (de) Ein bei der Expression von Nitrilase-Gen beteiligter regularischer Faktor, sowie dessen Gen
DE4140003C2 (de) Gentechnisch hergestellte Glutaminase und ihre Verwendung bei der antiviralen und Anti-Krebstherapie
EP0219839A2 (fr) Dérivé de l'interleukine-2, sa préparation et utilisation
DD251787A5 (de) Verfahren zur Herstellung eines Polypeptids oder eines Analogen desselben
DE3940651A1 (de) Verfahren zur expression von fremdgenen in hefen
DD296107A5 (de) Herstellungsverfahren fuer expressionsplasmide zur auspraegung reifer genprodukte in bakteriellen wirten

Legal Events

Date Code Title Description
PL Patent ceased